InnoCare Pharma Limited (HKG:9969)
Hong Kong
· Delayed Price · Currency is HKD 9.61
+0.09 (0.95%)
May 13, 2025, 1:45 PM HKT
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 19.99 billion as of May 12, 2025. Its market cap has increased by 113.59% in one year.
Market Cap
19.99B
Enterprise Value
14.24B
Revenue
1.07B
Ranking
n/a
PE Ratio
n/a
Stock Price
9.61
Market Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 12.28B to 19.99B, an increase of 62.79%. That is a compound annual growth rate of 9.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 19.99B | 58.21% |
| Dec 31, 2024 | 12.63B | -7.63% |
| Dec 29, 2023 | 13.68B | -44.57% |
| Dec 30, 2022 | 24.68B | 7.55% |
| Dec 31, 2021 | 22.95B | 32.04% |
| Dec 31, 2020 | 17.38B | 41.53% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 194.78B |
| Hansoh Pharmaceutical Group Company | 130.51B |
| JD Health International | 121.51B |
| WuXi Biologics | 94.43B |
| Innovent Biologics | 81.49B |
| Alibaba Health Information Technology | 80.09B |
| Akeso | 75.71B |
| Sichuan Kelun-Biotech Biopharmaceutical | 71.46B |